
A pilot study tested whether increasing REM sleep with suvorexant improves fear extinction recall in PTSD. While no direct drug effect was found, higher REM sleep correlated with reduced fear response, suggesting better extinction recall. This highlights REM sleep as a potential therapeutic target for PTSD treatment, warranting further research into suvorexant’s role in clinical populations.
Like
Save
Share